Efficacy of ALXN1840 on human biliary copper excretion quantified with 64CuCl2 PET/MR-scan
Latest Information Update: 14 Dec 2023
At a glance
- Drugs Tiomolibdate choline (Primary)
- Indications Hepatolenticular degeneration
- Focus Pharmacokinetics
- Acronyms ALXN1840WD-Cu-Excretion
- 09 Dec 2023 Results from EudraCT2020-005832-31 and EudraCT 2021-000102-25 , investigating the effects of TTM on copper absorption and biliary excretion published in the Journal of Hepatology
- 01 Jul 2022 Status changed from recruiting to completed.
- 28 Apr 2021 New trial record